SARS COV 2 Antibodies in R&D

Cape Bio Pharms is currently working on a very exciting collaboration to create a library of antibodies against the SARS-CoV-2 receptor binding domain. These antibodies have been extracted from PBMCS from rabbits immunized with the RBD antigen produced in plants. Through FACS sorting with CBP antigens fused to eGFP protein, as well as phage display and sequencing, we have a library of specific and high affinity antibodies against the RBD in development. These antibodies can be used in research and diagnosis of SARS-CoV-2.